Synchronous liver metastasis is on the rise, impacting surgical decisions and outcomes for various cancers.

• 6% of cancer patients developed synchronous liver metastasis between 2010 and 2021, with a 2.24% annual increase in the early years.
• Nearly 47.5% of cases were oligometastatic, leading to significantly better survival rates with surgery (5-year survival: 41% vs. 7.4%).

Understanding these trends can help tailor patient selection for surgical interventions, especially in oligometastatic cases.

• Colorectal, pancreatic, and small intestine cancers are notable for higher rates of oligometastatic liver metastasis.

A proposed classification enhances understanding of bleeding complications after total pancreatectomy, impacting surgical management.

• 35 patients experienced bleeding complications, highlighting a significant risk.
• The existing ISGPS classification fails to capture all relevant bleeding sources post-total pancreatectomy.

This novel classification offers a more precise framework for identifying and managing hemorrhagic events, aiding surgeons in improving patient outcomes.

• A new severity index correlates with bleeding sources, enhancing clinical decision-making.

ALPPS surgery enhances liver regeneration by allowing one lobe to proliferate while another manages metabolic tasks.

• The fast-regenerating lobe (FRL) increases growth when the metabolic load of the non-growing lobes (LLs) is appropriately managed.
• Transcriptomics and metabolomics show distinct roles: FRL focuses on growth while LLs handle metabolic support.

Surgeons can tailor surgical strategies based on metabolic capacity to optimize outcomes during ALPPS procedures.

• Reduced ligated volume enhances FRL growth by increasing metabolic activity in LLs, indicating a potential strategy for improving patient selection.

A validated preoperative scoring tool enhances surgical decision-making for laparoscopic splenectomy.

• Age, INR, splenic thickness, and cirrhosis are key predictors of operative difficulty.
• The 0-23 scoring system stratifies patients into low (0-7), intermediate (8-15), and high-risk (16-23) groups, offering strong accuracy (AUC 0.78 – 0.82).

High-risk patients experience increased blood loss, longer surgery times, and higher conversion rates to open surgery.

This tool can improve patient selection and optimize resource allocation in surgical planning.

Nonoperative treatments like splenic angioembolization show better outcomes than surgery for severe blunt splenic injuries.

• Morbidity is significantly lower with splenic angioembolization (odds ratio 0.61) and observation (odds ratio 0.71) compared to open splenectomy.
• Among hypotensive patients, there’s no mortality difference, but angioembolization and observation shorten hospital stays by about 1.4 days each.

Careful patient selection can favor nonoperative management strategies to optimize recovery and minimize complications.